Treatment hope for prion diseases

被引：0
|
作者：
Le Page, Michael
机构：
来源：
NEW SCIENTIST | 2023年 / 246卷 / 3443期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Potential treatment for prion diseases
    Borman, S
    CHEMICAL & ENGINEERING NEWS, 2002, 80 (33) : 42 - 42
  • [2] Potential approaches for heterologous prion protein treatment of prion diseases
    Seelig, Davis M.
    Goodman, Patricia A.
    Skinner, Pamela J.
    PRION, 2016, 10 (01) : 18 - 24
  • [3] Autophagy pathways in the treatment of prion diseases
    Abdelaziz, Dalia H.
    Abduirahman, Basant A.
    Gilch, Sabine
    Schatzl, Hermann M.
    CURRENT OPINION IN PHARMACOLOGY, 2019, 44 : 46 - 52
  • [4] Evaluation of quinacrine treatment for prion diseases
    Barret, A
    Tagliavini, F
    Forloni, G
    Bate, C
    Salmona, M
    Colombo, L
    De Luigi, A
    Limido, L
    Suardi, S
    Rossi, G
    Auvré, F
    Adjou, KT
    Salès, N
    Williams, A
    Lasmézas, C
    Deslys, JP
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8462 - 8469
  • [5] Prion diseases and emerging prion diseases
    Yokoyama, Takashi
    Mohri, Shirou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (09) : 912 - 916
  • [6] RNAi: a novel strategy for the treatment of prion diseases
    Kong, Qingzhong
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (12): : 3101 - 3103
  • [7] What are the prospects for pharmacological treatment of prion diseases?
    Adjou, KT
    Seman, M
    THERAPIE, 2002, 57 (02): : 123 - 127
  • [8] Psychotropic Medications and the Treatment of Human Prion Diseases
    Appleby, Brian S.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (05) : 353 - 362
  • [9] Prospects for the pharmacological treatment of human prion diseases
    Adjou, KT
    Deslys, JP
    Demaimay, R
    Seman, M
    Dormont, D
    CNS DRUGS, 1998, 10 (02) : 83 - 89
  • [10] Prospects for the Pharmacological Treatment of Human Prion Diseases
    Karim Tarik Adjou
    Jean-Philippe Deslys
    Rémi Demaimay
    Michel Seman
    Dominique Dormont
    CNS Drugs, 1998, 10 : 83 - 89
12345